NO20071653L - Krystallinske former av en pyrazolo'3,4-C pyridin faktor XA inhibitor. - Google Patents
Krystallinske former av en pyrazolo'3,4-C pyridin faktor XA inhibitor.Info
- Publication number
- NO20071653L NO20071653L NO20071653A NO20071653A NO20071653L NO 20071653 L NO20071653 L NO 20071653L NO 20071653 A NO20071653 A NO 20071653A NO 20071653 A NO20071653 A NO 20071653A NO 20071653 L NO20071653 L NO 20071653L
- Authority
- NO
- Norway
- Prior art keywords
- crystalline forms
- pyrazolo
- pyridine
- inhibitor
- factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Foreliggende oppfinnelse tilveiebringer krystallinske former av l-(3-klorfenyl)-7-okso-6-[4-(2-okso-l(2H)pyridinyl)fenyl]-4,5,6,7-tetrahydro-l/H-pyrazolo[3,4-c]pyridin-3-karboksamid og solvater derav; fremgangsmåter for fremstilling av slike krystallinske former; farmasøytiske preparater omfattende slike krystallinske former; og metoder for behandling av tromboemboliské lidelser med slike krystallinske former eller slike farmasøytiske preparater.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61365604P | 2004-09-28 | 2004-09-28 | |
US11/235,519 US7388096B2 (en) | 2004-09-28 | 2005-09-26 | Crystalline forms of a factor Xa inhibitor |
PCT/US2005/034512 WO2006036927A1 (en) | 2004-09-28 | 2005-09-27 | Crytalline forms of a pyrazolo `3, 4-c ! pyridine factor xa inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20071653L true NO20071653L (no) | 2007-03-30 |
Family
ID=36100111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20071653A NO20071653L (no) | 2004-09-28 | 2007-03-28 | Krystallinske former av en pyrazolo'3,4-C pyridin faktor XA inhibitor. |
Country Status (12)
Country | Link |
---|---|
US (1) | US7388096B2 (no) |
EP (1) | EP1819703A1 (no) |
JP (1) | JP2008514711A (no) |
KR (1) | KR20070067108A (no) |
AU (1) | AU2005289599A1 (no) |
BR (1) | BRPI0516171A (no) |
CA (1) | CA2582223A1 (no) |
IL (1) | IL182148A0 (no) |
MX (1) | MX2007003426A (no) |
NO (1) | NO20071653L (no) |
RU (1) | RU2007115859A (no) |
WO (1) | WO2006036927A1 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7304157B2 (en) | 2004-09-28 | 2007-12-04 | Bristol-Myers Squibb Company | Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
RU2007126770A (ru) * | 2004-12-15 | 2009-01-27 | Бристол-Маерс Сквибб Компани (Us) | Кристаллические формы ингибитора фактора ха |
DE102008037025C5 (de) * | 2008-08-08 | 2016-07-07 | Jesalis Pharma Gmbh | Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform |
CA2959987C (en) * | 2014-09-02 | 2023-05-09 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Pyrazolo[3,4-c]pyridine compounds and their anti-thrombosis effect |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2345993C2 (ru) | 2001-09-21 | 2009-02-10 | Бристол-Маерс Сквибб Компани | ЛАКТАМСОДЕРЖАЩЕЕ СОЕДИНЕНИЕ И ЕГО ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Xa |
TWI331526B (en) | 2001-09-21 | 2010-10-11 | Bristol Myers Squibb Pharma Co | Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
US7304157B2 (en) * | 2004-09-28 | 2007-12-04 | Bristol-Myers Squibb Company | Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
-
2005
- 2005-09-26 US US11/235,519 patent/US7388096B2/en not_active Expired - Fee Related
- 2005-09-27 KR KR1020077006953A patent/KR20070067108A/ko not_active Application Discontinuation
- 2005-09-27 CA CA002582223A patent/CA2582223A1/en not_active Abandoned
- 2005-09-27 AU AU2005289599A patent/AU2005289599A1/en not_active Abandoned
- 2005-09-27 BR BRPI0516171-1A patent/BRPI0516171A/pt not_active Application Discontinuation
- 2005-09-27 MX MX2007003426A patent/MX2007003426A/es not_active Application Discontinuation
- 2005-09-27 RU RU2007115859/04A patent/RU2007115859A/ru not_active Application Discontinuation
- 2005-09-27 WO PCT/US2005/034512 patent/WO2006036927A1/en not_active Application Discontinuation
- 2005-09-27 JP JP2007534700A patent/JP2008514711A/ja active Pending
- 2005-09-27 EP EP05805620A patent/EP1819703A1/en not_active Withdrawn
-
2007
- 2007-03-22 IL IL182148A patent/IL182148A0/en unknown
- 2007-03-28 NO NO20071653A patent/NO20071653L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2005289599A1 (en) | 2006-04-06 |
US20060069118A1 (en) | 2006-03-30 |
WO2006036927A1 (en) | 2006-04-06 |
MX2007003426A (es) | 2007-05-10 |
IL182148A0 (en) | 2007-07-24 |
JP2008514711A (ja) | 2008-05-08 |
RU2007115859A (ru) | 2008-11-10 |
KR20070067108A (ko) | 2007-06-27 |
CA2582223A1 (en) | 2006-04-06 |
BRPI0516171A (pt) | 2008-08-26 |
US7388096B2 (en) | 2008-06-17 |
EP1819703A1 (en) | 2007-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008002717A1 (es) | 3-(1-clorofenil)-7-oxo-6-[4-(2-oxo-1(2h)piridinil)fenil]-4,5,6,7-tetrahidro-1h-pirazolo[3,4-c]piridin-3-carboxamida y 3-(1-hidroxi-1-metil-etil)-1-(a-metoxi-fenil)-6-[4-(2-oxo-2h-piridin-1-il)-fenil]-1,4,5,6-tetrahidro-pirazolo[3,4-c]piridin-7-ona; composicion farmaceutica; combinacion farmaceutica y uso en el tratamiento de un desorden tromboembolico | |
AU2003297160A1 (en) | Benzisoxazole derivatives useful as inhibitors of protein kinases | |
NO20064000L (no) | Heteroarylkoblede pyrazoloderivater | |
WO2002087513A3 (en) | Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 | |
AP1767A (en) | 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones. | |
NO20066055L (no) | Pyridinderivater | |
NO20045461L (no) | Nye pyridazin 3-(2H)-on derivater som PDE4-inhibitorer | |
NO20053046L (no) | 4-okso-1(3-substituerte fenyl-1,4-dihydro-1,8-naftyridin-3-karboksamidfosfodiesterase-4-inhibitorer. | |
NO20061454L (no) | Compounds having CRTH2 antagonist activity | |
WO2000035886A3 (en) | (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors | |
WO2005049581A8 (en) | Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors | |
NO20082065L (no) | Nye imidazo[4,5-b]pyridinderivater som inhibitorer av glykogensyntasekinase 3 for anvendelse ved behandling av demens og neurodegenerative forstyrrelser | |
NO20051695L (no) | Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer | |
WO2005095409A3 (en) | Tetrahydroquinoline derivatives and a process for preparing the same | |
NO20064015L (no) | Kondenserte derivater av pyrazol | |
WO2007013896A3 (en) | Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors | |
WO2004043337A3 (en) | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides | |
NO20062256L (no) | Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner | |
MY138737A (en) | N3-substituted imidazopyridine c-kit inhibitors | |
NO20071653L (no) | Krystallinske former av en pyrazolo'3,4-C pyridin faktor XA inhibitor. | |
NO20071634L (no) | Effektiv syntese av 4,5-dihydro-pyrazolo(3,4-C)pyrid-2-oner | |
AU2002356251A1 (en) | 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-(3.2.2)nonane derivatives, preparation and therapeutic use thereof | |
MXPA03001356A (es) | Nuevos agentes inhibidores de beta-amiloides, procedimientos para su preparacion y su uso como medicamentos. | |
NO20072666L (no) | Krystallinske former av en faktor Xa-inhibitor | |
EP1736155A4 (en) | MEDICAMENT COMPRISING A COMBINATION OF AN ACETYLCHOLINE ESTERASE INHIBITOR AND A SUBSTITUTED 3-OXADIAZOLYL-1,6-NAPHTHYRIDIN-2 (1H) -ONE DERIVATIVE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |